US 12103926
Compounds for treating huntington's disease
granted A61PA61P25/28
Quick answer
US patent 12103926 (Compounds for treating huntington's disease) held by PTC THERAPEUTICS, INC. expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P25/28